Clinical trials
Phase 1/2 Urinary Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
119 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 3 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 11 |
| 2020 | 5 |
| 2021 | 16 |
| 2022 | 9 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 9 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 45 |
| Terminated | 24 |
| Recruiting | 22 |
| Active, not recruiting | 13 |
| Unknown status | 7 |
| Not yet recruiting | 4 |
| Withdrawn | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 5 |
| Merck Sharp & Dohme LLC | 3 |
| Altor BioScience | 2 |
| AstraZeneca | 2 |
| BicycleTx Limited | 2 |
| Cancer Research UK | 2 |
| Hoffmann-La Roche | 2 |
| National Cancer Institute (NCI) | 2 |
| Pfizer | 2 |
| Rainier Therapeutics | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 119 |
| Carcinoma, Non-Small-Cell Lung | 24 |
| Ovarian Neoplasms | 24 |
| Carcinoma, Transitional Cell | 22 |
| Stomach Neoplasms | 22 |
| Breast Neoplasms | 17 |
| Colorectal Neoplasms | 17 |
| Non-Muscle Invasive Bladder Neoplasms | 17 |
| Prostatic Neoplasms | 17 |
| Esophageal Neoplasms | 16 |
Trials
Showing 51 to 75 of 119. Each trial links to its page on Pharma Observatory.
19 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.